Chinese traditional medicines composition took orally for treating hyperlipaemia

A composition and technology of hyperlipidemia, applied in the direction of drug combination, pharmaceutical formula, plant raw materials, etc., can solve the problems of ineffective treatment, delayed treatment, single treatment of lipid-lowering drugs, etc.

Inactive Publication Date: 2007-09-19
于春杰
View PDF0 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] The lipid-lowering drugs commonly used in clinical practice are only a single treatment
Some only lower cholesterol, and some only lower triglycerides. Medication will not only fail to cure, but delay treatment, and eventually induce co

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0027] Example 1: This kind of traditional Chinese medicine composition for oral treatment of hyperlipidemia, the crude drug made of active ingredients is as follows in parts by weight: rhubarb 10, cassia seed 12, salvia miltiorrhiza 10, ginseng 5, eucommia ulmoides 8, sangjisheng 10, schisandra 10. Wolfberry 10, Polygonum multiflorum 15, Hawthorn 15 and Alisma 15.

[0028] Shuijianbi 1 dose per day, 2 times a day. 15 days is a course of treatment.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a traditional Chinese drug composition to be taken orally for hyperlipidemia, belonging to traditional Chinese medicine domain. The raw medicine of the said composition as active ingredient are as follows by weight: rhheum 10, cassia seed 12, radix salviae miltiorrhizae 10, panax 5, eucommia 8, parasite scurrula 10, schisandra 10, wolfberry 10, fleece-flower root 15, haw 15 and alisma rhizome 15. The composition is decocted in water, one decoction for 2 doses a day, and 15 days made up one course. The composition warms kidney yang, activates blood circulation to dissipate blood stasis, reduces cholesterol content and blood fat, controls atherosclerosis without untoward reactions such as toxicity of kidney and liver induced by common blood lipid-lowering drugs and myotoxicity.

Description

technical field [0001] The invention relates to a traditional Chinese medicine composition for oral administration for treating hyperlipidemia, which belongs to the field of traditional Chinese medicines. Background technique [0002] Hyperlipidemia, also known as hyperlipidemia, refers to abnormal fat metabolism in the human body causing increased blood lipids in the blood, or changes in blood lipid levels beyond the normal range. Common hyperlipidemia changes are manifested as abnormalities in one or more of the following indicators: (1) elevated serum total cholesterol levels; (2) elevated serum triglyceride levels; (3) serum high-density lipoprotein cholesterol levels Abnormally reduced. In fact, it is more accurate to replace serum total cholesterol with serum low-density lipoprotein cholesterol, because the total cholesterol level roughly reflects the total level of all lipoproteins. [0003] The formation of hyperlipidemia is due to the dysfunction of viscera and th...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/884A61P3/06
Inventor 于春杰徐恒雁
Owner 于春杰
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products